| Literature DB >> 36193198 |
Li Tang1,2,3,4, Hailun Zhou1,2,3,4, Donghui Chen1,2,3,4, Rong Xiang1,2,3,4, Jianjia Tang1,2,3,4.
Abstract
Objective: Peri-implantitis (PI) is one of the main reasons for dental implant failure. Until now, the etiology and pathogenesis of PI remain unclear.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36193198 PMCID: PMC9525745 DOI: 10.1155/2022/4202823
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.809
List of top 20 differentially expressed genes.
| Gene | Description | logFC |
| FDR |
|---|---|---|---|---|
| BT_HI-vs-BT_PI | ||||
| ZMPSTE24 | Zinc metallopeptidase STE24 | 0.05436861 | 0.000425 | 0.418 |
| TUBB4B | Tubulin beta 4B class IVb | 0.067058028 | 0.000776 | 0.418 |
| EIF3M | Eukaryotic translation initiation factor 3 subunit M | 0.163804868 | 0.000305 | 0.418 |
| RAB10 | RAB10, member RAS oncogene family | 0.144274808 | 0.000823 | 0.418 |
| SF3A3 | Splicing factor 3a subunit 3 | 0.040577086 | 0.001089 | 0.418 |
| AP1G1 | Adaptor related prot | 0.056817586 | 0.001125 | 0.418 |
| C20orf203 | Chromosome 20 open reading frame 203 | -0.129391728 | 0.000552 | 0.418 |
| MIR15B | microRNA 15b | -0.141409803 | 0.000692 | 0.418 |
| MIR214 | microRNA 214 | -0.115661557 | 0.000828 | 0.418 |
| MIR99A | microRNA 99a | -0.073109217 | 0.001108 | 0.418 |
| OCIAD1 | OCIA domain containing 1 | 0.123431672 | 0.001013 | 0.418 |
| CAV1 | Caveolin 1 | 0.093133672 | 0.00071 | 0.418 |
| BRK1 | BRICK1 subunit of SCAR/WAVE actin nucleating complex | 0.065658554 | 0.000527 | 0.418 |
| PPP6C | Protein phosphatase 6 catalytic subunit | 0.03378179 | 0.000684 | 0.418 |
| PSMB3 | Proteasome subunit beta 3 | 0.135521691 | 0.000908 | 0.418 |
| PSMD10 | Proteasome 26S subunit, non-ATPase 10 | -0.152847334 | 0.000283 | 0.418 |
| HIST1H2BG | Histone cluster 1 H2B family member g | 0.112335029 | 0.000385 | 0.418 |
| SNRPG | Small nuclear ribonucleoprotein polypeptide G | 0.149342222 | 0.000241 | 0.418 |
| DCTN5 | Dynactin subunit 5 | 0.119709276 | 0.000526 | 0.418 |
| CAPZA1 | Capping actin protein of muscle Z-line subunit alpha 1 | 0.145481101 | 0.000343 | 0.418 |
| GT_HI-vs-GT_PI | ||||
| NEFM | Neurofilament, medium polypeptide | -1.4062788 | 0.00000032 | 0.0106 |
| MAPT | Microtubule associated protein tau | -1.83338262 | 0.00000206 | 0.0246 |
| MERTK | MER proto-oncogene, tyrosine kinase | 1.01973984 | 0.00000295 | 0.0246 |
| MRC1 | Mannose receptor, C type 1 | 1.01068439 | 0.00000588 | 0.029 |
| GLIPR2 | GLI pathogenesis related 2 | 0.86823054 | 0.00000688 | 0.029 |
| SLC2A3 | Solute carrier family 2 member 3 | 1.26464786 | 0.00000736 | 0.029 |
| SLCO2B1 | Solute carrier organic anion transporter family member 2B1 | 0.84589762 | 0.00000911 | 0.029 |
| SRPX2 | Sushi repeat containing protein, | 1.27391664 | 0.00000938 | 0.029 |
| CD14 | CD14 molecule | 1.33965561 | 0.00000996 | 0.029 |
| MSR1 | Macrophage scavenger receptor 1 | 1.17709016 | 0.00001044 | 0.029 |
| C1QB | Complement C1q B chain | 0.83761875 | 0.00001224 | 0.0313 |
| STAC2 | SH3 and cysteine rich domain 2 | -1.18651859 | 0.00001325 | 0.0313 |
| CHRNA3 | Cholinergic receptor nicotinic alpha 3 subunit | -0.94702121 | 0.00001433 | 0.0313 |
| CTGF | Connective tissue growth factor | 1.32968345 | 0.00001505 | 0.0313 |
| CASP10 | Caspase 10 | 0.66524239 | 0.00001683 | 0.033 |
| TLR4 | Toll like receptor 4 | 1.40463223 | 0.00001948 | 0.036 |
| MS4A6A | Membrane spanning 4-domains A6A | 0.91872666 | 0.00002886 | 0.0494 |
| C3AR1 | Complement component 3a receptor 1 | 1.07948921 | 0.00003202 | 0.0494 |
| CMAHP | Cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 0.79185305 | 0.00003378 | 0.0494 |
| SRGN | Serglycin | 1.37684391 | 0.00003424 | 0.0494 |
Figure 1Visualization of differentially expressed gene and enrichment analysis. (a) Principal component analysis of microarray expression profiles of bone and gingival tissue. (b) Cluster analysis of microarray expression profiles of bone and gingival tissue. (c) Heatmap of enriched terms across the differentially expressed gene, colored by P values.
List of top 10 enriched GO terms and pathways.
| GO | Category | Description | Count | % | Log10 ( | Log10 ( |
|---|---|---|---|---|---|---|
| BT_HI-vs-BT_PI | ||||||
| R-HSA-8953897 | Reactome gene sets | Cellular responses to external stimuli | 105 | 5.1 | -15.97 | -11.66 |
| hsa04141 | KEGG pathway | Protein processing in endoplasmic reticulum | 46 | 2.23 | -12.45 | -9.03 |
| GO:0006888 | GO biological processes | ER to Golgi vesicle-mediated transport | 54 | 2.62 | -12.3 | -8.94 |
| R-HSA-6798695 | Reactome gene sets | Neutrophil degranulation | 86 | 4.18 | -10.54 | -7.42 |
| R-HSA-5619115 | Reactome gene sets | Disorders of transmembrane transporters | 43 | 2.09 | -9.82 | -6.99 |
| GO:0048514 | GO biological processes | Blood vessel morphogenesis | 105 | 5.1 | -8.45 | -5.95 |
| GO:0006412 | GO biological processes | Translation | 108 | 5.25 | -8.39 | -5.91 |
| GO:0044257 | GO biological processes | Cellular protein catabolic process | 110 | 5.34 | -7.33 | -5.06 |
| R-HSA-72766 | Reactome gene sets | Translation | 52 | 2.53 | -6.6 | -4.44 |
| GO:0060627 | GO biological processes | Regulation of vesicle-mediated transport | 81 | 3.93 | -6.57 | -4.42 |
| GT_HI-vs-GT_PI | ||||||
| GO:0002274 | GO biological processes | Myeloid leukocyte activation | 194 | 8.1 | -45.73 | -41.42 |
| GO:0046649 | GO biological processes | Lymphocyte activation | 200 | 8.35 | -40.59 | -36.88 |
| GO:0040017 | GO biological processes | Positive regulation of locomotion | 162 | 6.76 | -33.22 | -29.8 |
| GO:0050900 | GO biological processes | Leukocyte migration | 143 | 5.97 | -31.7 | -28.56 |
| GO:0001568 | GO biological processes | Blood vessel development | 183 | 7.64 | -29.38 | -26.44 |
| GO:0043062 | GO biological processes | Extracellular structure organization | 124 | 5.18 | -28.7 | -25.81 |
| GO:0001816 | GO biological processes | Cytokine production | 179 | 7.47 | -25.89 | -23.11 |
| R-HSA-109582 | Reactome gene sets | Hemostasis | 147 | 6.14 | -23.42 | -20.68 |
| GO:0002764 | GO biological processes | Immune response-regulating signaling pathway | 153 | 6.39 | -22.13 | -19.41 |
| GO:0030029 | GO biological processes | Actin filament-based process | 164 | 6.84 | -21.6 | -18.9 |
Figure 2Weighted gene coexpression network analysis of microarray data. (a) Sample dendrogram and trait heatmap: the red representation in the graph is marked as nonzero samples in the trait data. (b) Gene dendrogram with trait: this figure is divided into three parts. The first part is the phylogenetic clustering tree of genes. The second part shows the module color display of the corresponding genes. The third part shows the correlation between the genes in each character-related sample and its module. The redder the color, the more positive the correlation. The negative correlation is blue. (c) Gene saliency map of module blue and turquoise members: scatter plot of module kME value and gene saliency value, higher the core value, smaller the P value, and the module members can represent the module characteristics better.
Figure 3Weighted Gene coexpression network analysis of RNA-seq data. (a) Principal component analysis of RNA-seq expression profiles of gingival tissue. (b) Sample dendrogram and trait heatmap of RNA-seq data. (c) Gene dendrogram with a trait of RNA-seq data. (d) Module-trait correlation thermograms: correlation of thermograms between modules and given traits. The closer the correlation between trait and module to the absolute value of 1; the trait is related to the gene function of the module. (e) Heatmap of enriched terms across module gene members, colored by P values.
Enrichment analysis results of modules.
| Module | GO | Description | Log10 ( |
|---|---|---|---|
| kMEblack | GO:0002250 | Adaptive immune response | -7.69 |
| GO:0042113 | B cell activation | -6.40 | |
| GO:0097190 | Apoptotic signaling pathway | -6.12 | |
| GO:0002285 | Lymphocyte activation involved in immune response | -4.83 | |
| GO:0001816 | Cytokine production | -4.63 | |
| kMEblue | GO:0001816 | Cytokine production | -35.63 |
| GO:0030155 | Regulation of cell adhesion | -33.09 | |
| GO:0002250 | Adaptive immune response | -32.10 | |
| GO:0002366 | Leukocyte activation involved in immune response | -28.75 | |
| GO:0019221 | Cytokine-mediated signaling pathway | -26.74 | |
| kMEcyan | GO:0002366 | Leukocyte activation involved in immune response | -14.65 |
| GO:0019221 | Cytokine-mediated signaling pathway | -14.53 | |
| hsa04060 | Cytokine-cytokine receptor interaction | -13.45 | |
| GO:0042330 | Taxis | -11.47 | |
| GO:0009617 | Response to bacterium | -10.84 | |
| kMEdarkred | R-HSA-6809371 | Formation of the cornified envelope | -6.80 |
| GO:0042552 | Myelination | -3.54 | |
| GO:0008203 | Cholesterol metabolic process | -3.36 | |
| GO:0016485 | Protein processing | -2.38 | |
| M5885 | NABA matrisome associated | -2.22 | |
| kMEgreen | GO:0008544 | Epidermis development | -26.58 |
| GO:0001942 | Hair follicle development | -12.11 | |
| GO:0048729 | Tissue morphogenesis | -9.51 | |
| GO:0008610 | Lipid biosynthetic process | -6.79 | |
| GO:0000904 | Cell morphogenesis involved in differentiation | -6.75 | |
| kMElightcyan | GO:0042113 | B cell activation | -10.34 |
| GO:0002366 | Leukocyte activation involved in immune response | -8.24 | |
| GO:0002253 | Activation of immune response | -8.06 | |
| R-HSA-1280218 | Adaptive immune system | -7.80 | |
| GO:0002250 | Adaptive immune response | -7.76 | |
| kMElightgreen | GO:0070268 | Cornification | -13.86 |
| GO:0008544 | Epidermis development | -11.51 | |
| GO:0070841 | Inclusion body assembly | -6.97 | |
| R-HSA-1461957 | Beta defensins | -4.12 | |
| GO:0033559 | Unsaturated fatty acid metabolic process | -2.86 | |
| kMEmidnightblue | GO:0009617 | Response to bacterium | -7.61 |
| GO:0002366 | Leukocyte activation involved in immune response | -7.51 | |
| hsa05150 | Staphylococcus aureus infection | -6.94 | |
| GO:0007249 | I-kappaB kinase/NF-kappaB signaling | -6.77 | |
| GO:0001816 | Cytokine production | -6.55 | |
| kMEpurple | GO:0000904 | Cell morphogenesis involved in differentiation | -4.37 |
| GO:0048729 | Tissue morphogenesis | -3.87 | |
| GO:0048598 | Embryonic morphogenesis | -3.62 | |
| GO:0022604 | Regulation of cell morphogenesis | -3.52 | |
| GO:0030155 | Regulation of cell adhesion | -3.29 | |
| kMEred | R-HSA-156902 | Peptide chain elongation | -7.09 |
| R-HSA-201681 | TCF dependent signaling in response to WNT | -4.97 | |
| GO:0033131 | Regulation of glucokinase activity | -3.45 | |
| GO:0051013 | Microtubule severing | -3.32 | |
| GO:0090277 | Positive regulation of peptide hormone secretion | -3.28 | |
| kMEroyalblue | GO:0001503 | Ossification | -4.32 |
| GO:0001501 | Skeletal system development | -3.78 | |
| hsa04514 | Cell adhesion molecules (CAMs) | -3.35 | |
| GO:0045596 | Negative regulation of cell differentiation | -3.02 | |
| GO:0010942 | Positive regulation of cell death | -2.21 |
Figure 4Significance analysis and signaling pathway analysis of key gene Modules. (a) Gene saliency map of module purple, green, and red members. (b) Column graphs of enriched terms across three modules genes members, colored by P values.
Figure 5Genes expression analysis of key gene modules. Expression of key gene module members.